ChromaCode key facts
as of Oct 2026- Developer of a molecular diagnostics technology designed to connect patients to the treatment through smarter, accessible diagnostics.
- ChromaCode is valued at approximately $153.0M as of Oct 2026 (last reported valuation).
- It has raised $101.0M across 5 recorded rounds; the latest was Seed Round ($3.8M) in Jan 2025.
- Notable investors include Global Brain, New Enterprise Associates, In-Q-Tel, Okapi Venture Capital, California Institute of Technology Endowment — 14 tracked in total.
- ChromaCode has filed 7 Form Ds with the SEC since 2017, most recently Feb 2025 ($3.8M sold to 4 investors).
- Status: Privately Held (backing).
ChromaCode's last reported valuation, Feb 2023. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch ChromaCode: the Monday email on marks, rounds and moves
ChromaCode funding rounds
5 roundsWho backs ChromaCode
14+ChromaCode valuation
ChromaCode's last reported valuation was $153 million in Feb 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has ChromaCode raised?
ChromaCode has raised $101 million across 5 recorded rounds since 2017. The largest was a $38.6 million early-stage round in Aug 2019; the most recent was a $3.8 million seed round in Jan 2025.
ChromaCode has filed 7 Form Ds with the SEC since 2017, most recently in Feb 2025 ($3.8 million sold to 4 investors).
ChromaCode investors
14 investors are on record for ChromaCode, including Global Brain, New Enterprise Associates, In-Q-Tel and Okapi Venture Capital. The seed round in Jan 2025 drew 4 investors.
About ChromaCode
Developer of a molecular diagnostics technology designed to connect patients to the treatment through smarter, accessible diagnostics. The company's technology blends signal processing and tailored chemistry to allow for multiplexed, low-cost chemistry that integrates into existing laboratory workflows, enabling laboratories to carry out testing of multiple targets in a single sample on common, existing quantitative polymerase chain reaction instrumentation.
- Sector
- Healthcare
- HQ
- Carlsbad, CA, United States
- Founded
- 2012
- Employees
- 65
- Website
- chromacode.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.